MANUFACTURING ARTICLES

MANUFACTURING VIDEOS

There are many different criteria for selecting a CDMO for your mRNA products. Arcturus’ Qian Ruan explains that a product’s stage of development and the specific needs inherent to that phase of development should be an important guide for companies today, especially given the expansion of the outsourcing sector and the wide range of capabilities.

Listen in on a discussion surrounding questions about chromatography and column-free processes in the development of mRNA vaccines and therapeutics.

We discuss key components and common pain points of scaling up nanomedicine production and use recent publications to walk customers through the process.

The emergence of RNA-encapsulated-lipid nanoparticles has introduced a seismic shift in biopharma innovation. But how will the industry adapt to diversifying applications and scales going forward?

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS